Cervical

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
55962
A randomized phase III trial for evaluation of usefullness of pelvic drains after radical hysterectomy and node dissection (RHND)
55954
A randomized phase III study of chemotherapy and radiotherapy versus radiotherapy alone as adjuvant treatment to patients with node positive stages Ib or IIa cervix cancer (EO ORTC/NSGO/COSA/MRC intergroup trial)
55842
Phase II trial of 4'-epiDoxorubicin in disseminated carcinoma of the uterine cervix
04922
A phase II study of CPT-11 in patients with advanced and/or recurrent cervical carcinoma without previous chemotherapy
55883
Phase II study of Navelbine in patients with advanced and/or recurrent cervical carcinoma
04861
Etude clinique phase II 4' -0-tetrahydropyranyl adriamycine (THP-ADM-1609 RB)
55857
Phase II trial of 5-aza-2'-deoxycytidine in patients with advanced or recurrent squamous cell carcinoma of the uterine cervix
55851
Phase II trial of a combination of vindesine, Cisplatin, bleomycin, and mitomycin-C (BEMP) in disseminated squamous cell carcinoma of the uterine cervix
55863
Randomized phase III trial of vindesine, Cisplatin, bleomycin and mitomycin-C (BEMP) versus Cisplatin (P) in disseminated squamous cell carcinoma of the uterine cervix
55994
Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant radiotherapy and chemotherapy in FIGO Ib2, IIa > 4 cm or IIb cervical cancer.

Back to Site-list